You are here: Industry Insights > Protein

News List

Evozyne, Takeda Ink Strategic Protein Design Agreement contractpharma
January 29, 2021
Takeda will use Evozyne's evolution-based protein design technology to research and develop proteins for next-gen gene therapies.
JS Bio and Etta Biotech Advancing Partnership contractpharma
January 20, 2021
Jianshun Biosciences (JS Bio) recently formed its strategic partnership with Etta Biotech to set up a high titer transient protein expression platform for high quality protein production using JS Bio’s transient transfection media.
AbbVie partners with Frontier Medicines on protein degrader development pharmatimes
December 04, 2020
AbbVie has announced a new partnership with precision medicine company Frontier Medicines to discover and develop small molecules therapeutics for difficult-to-treat protein targets.
Contact tracing inside infected cells offer new clues about SARS-CoV-2 virus: Study expresspharma
September 23, 2020
The findings of this research could lead to better diagnostics or new treatments, as well as helping to explain what makes this virus so good at the process of infection.
Map of ammonium’s journey may prevent infection expresspharma
July 28, 2020
By improving our understanding of the normal function of ammonium transporters, we can gain insight into how specific malfunctions lead to disease, say researchers.
A protein that helps to fight viruses can also block lung damage repair worldpharmanews
June 17, 2020
Researchers at the Francis Crick Institute have found that a protein which is initially helpful in the body's immune response to a virus, can later interfere with the repair of lung tissue.
Chinese, US scientists identify bacterial secreted proteins that can inactivate coronavirus expresspharma
May 27, 2020
This can provide a future avenue for the development of broad-spectrum antiviral drugs that might reduce the clinical burden caused by emerging viral diseases, according to a paper released on bioRxiv.
Utilising CRISPR could reduce contamination in recombinant-protein drugs europeanpharmaceuticalreview
May 05, 2020
Researchers have used CRISPR-Cas to edit the genes of contaminating proteins in mammalian cells used to produce recombinant-protein drugs, which could reduce costs and strengthen quality.
‘Directing’ evolution to identify potential drugs earlier in discovery expresspharma
April 14, 2020
Scientists have developed a technique that could significantly reduce the time to discover potential new antibody-based drugs to treat disease.
Takeda, Evox link up to the tune of $882m pharmatimes
March 30, 2020
Evox has announced a new rare disease collaboration with Takeda to develop up to five novel protein replacement and mRNA therapies.

Previous page 1 2 3 4 5 6 7 8 9 Next page